Hodogaya Chemical Co., Ltd.
(Disclosure matters progress) Notice regarding the completion of acquisition of interests in Framochem Francia-Magyar Finomkemiai Kft (full subsidiary)
Acquisition of Framochem Francia-Magyar Finomkemiai Kft has been completed. Framochem has become a wholly owned subsidiary, accelerating the build-out of a Europe-Japan hub. Emphasizes the strategic significance of the new medium-term plan CODE/CHORD 2030.
Key Figures
- Acquisition completion date: August 25, 2026
- New Medium-Term Plan CODE/CHORD 2030: 5-year plan, focusing on the transformative 3 years
- Market expansion through the Japan-Europe double-hub framework
AI要約
Overview
This notice confirms the completion of the acquisition of Framochem Francia-Magyar Finomkemiai Kft, formalizing Hodogaya Chemical Group's status as a wholly owned subsidiary. Closing took place as of August 25, 2026, and business activities will be fully pursued under the new framework. By integrating Framochem's strong position in the European market with Hodogaya Chemical's long-standing technical capabilities and global reach, the goal is to establish a Japan-Europe double-hub to strengthen competitiveness in the world market for phosgene derivatives.
Strategy and Outlook
Positioned as the first step in the non-disruptive growth strategy within the new medium-term management plan CODE/CHORD 2030, with a focus on strengthening the specialty chemicals domain in the functional resin segment. For the next five-year plan period, three years will be dedicated to transformation, with growth strategies including M&A. Further disclosure on future performance outlook will be provided as necessary.
Hodogaya Chemical Industry Co., Ltd.
Company overview · Stock price · Financial data · All IR